1 / 18

rsgf.co.uk InfoLab Mark Wyatt Wednesday 5 th December 2007

www.rsgf.co.uk InfoLab Mark Wyatt Wednesday 5 th December 2007. EV – fund management organisation. Institutional funds – investing for return Technology three funds - £34 million investing in technology RisingStars Growth Fund I RisingStars Growth Fund II SYIF Pilot Seedcorn Fund

saxon
Download Presentation

rsgf.co.uk InfoLab Mark Wyatt Wednesday 5 th December 2007

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. www.rsgf.co.uk InfoLab Mark Wyatt Wednesday 5th December 2007

  2. EV – fund management organisation Institutional funds – investing for return Technology three funds - £34 million investing in technology RisingStars Growth Fund I RisingStars Growth Fund II SYIF Pilot Seedcorn Fund Private Equity Coalfields Enterprise Fund - £10m MBOs, expansion capital former English coalfield regions but focus on Yorkshire, North East and East Midlands 3rd most active VC investor in the UK * * Source: Ernst & Young Venture Capital Insights Report 2004-2005 and 2005-2006

  3. Venture Capital – Early Stage Technology Approach What do we do? provide start up and early stage seed capital to high growth technology businesses – sector agnostic predominantly in the North of England investment range £50k to £1.5m taking proof of concept investments to AIM listings, Series A rounds and trade sales

  4. Technology team • Julian Viggars (39) • Head of Technology Investment • Previously Investment Director, latterly NXD BioProjects Plc and Barclays Ventures • At BioProjects – responsible for 2 largest investments, both start-ups. 1 sold recently for up to $100m. 1 listed on AIM – current value c.£40m • BioProjects investors at IPO 1.5x cash • 4 years at EV • Dr Mark Wyatt (35) • Investment Director • Formerly at Merlin BioSciences • 9 RSGF deals, IPO of Plant Impact plc • Sectors: medtech (pharma) and environmental • 4 years at EV • Edward French (39) • Investment Director • Previously MD of Bradford University commercialisation company – 7 spin outs formed • Previously Chairman of UNICO – UK University spin-out association • 13 early stage pre-revenue technology deals for RSGF • 5 years at EV • Dr Mark Rahn (36) • Investment Manager • PhD and MBA from Manchester Business School • Freelance consultant to the early stage tech and seed VC industries – NESTA, NStar and University of Manchester • Joined EV in 2006

  5. Why use venture capital? Advantages Money to grow the business more quickly New contacts and management help New networks New business insight Disadvantages Investors look for a high rate of return Requires giving up a stake in the business High levels of information required Control and rewards shared

  6. Networks – key to achieving competitive advantage

  7. What is a fundable project? It is not as simple as “I’ve invented a super technology” It is not a business plan with 200 pages of technical detail It is about the creation of a business opportunity that will give a fair return to all existing and future stakeholders

  8. Typical early stage technology VC operating model • Investment Principles • Tranched Investments • Lead Investor / Syndication • Clean Starts / early stage • Business building • Right to Appoint NXDs • Exit and Cash Focus Investment Criteria Differential value IPR - protectable position Clear exit potential Large market / unmet need Milestones People Prior knowledge and network Valuation & funding strategy

  9. Sectors of Interest

  10. Regional investors - invest locally, but think globally Next Device Acquired by USA business Experience of bus. dev. in Korea Peckforton Indian partners Acal CEO based in Japan USA based NXDs Plant Impact USA / European / Middle East

  11. Wadaro – starting point • Strong founders, been involved in one successful VC backed business before – Magic4 • Founder investing alongside VCs, demonstrating belief in the business, sharing risk and upside • Extremely well organised for a start up – clear milestones • Required funds to develop technology

  12. Wadaro – now • RSGF II and NWBIS (YFM) invested • Sector NXD on Board • Partnering discussion ongoing

  13. Chromatide – starting point • Creative technical founder with industrial background and credible technical reference points • Low level service turnover, and one royalty bearing development contract • Interesting technology that required investment • Scaleable • IP protection • Numerous market opportunities, but no clear commercial strategy

  14. Chromatide – now • Recruited non-executive chairman and SAB • Refined strategy with expert consultants • First investment: brought in knowledgeable co-investor (Malcolm Stewart at Liverpool Ventures) • Identified potential CEO • Entered into commercial agreement with Eka Chemicals, part of Akzo • Expanded technical resource and secured GRAND award to further explore platform technology • Development work underway, commercial interest already identified

  15. Not all VCs are the same Do your homework Look them up in the BVCA directory Check out what they have been investing in on their website Call them to pre-qualify interest Focus your efforts on those that look like they invest in opportunities that resemble yours

  16. Pitching to VCs Not all VCs require a plan, but they do require thought out and well present propositions Keep it simple and clear Remember, VCs need an exit, so how will you provide one Demonstrate you know how to reduce the risks in the venture Demonstrate openness, and think about how you answer questions

  17. RSGF II – outlook Significant experience to date with RSGF I Commitment to tranched investment model Plans to achieve earlier syndication Chromatide with MSIF, Wadaro with NWBIS (YFM) two more syndicated deals in legals Focus on investee team building and evolution Build balanced portfolio

  18. Questions?

More Related